David Protein Says ‘Diet’ Trends Are Over, GLP-1s Upend Markets
David Rahal, founder and CEO of David Protein, argues GLP-1 drugs have upended the diet-trend cycle, reshaping how br...
Compare high yield versus low fee strategies in dividend investing to determine which factor more strongly influences long-term performance.
27,099 articlesDavid Rahal, founder and CEO of David Protein, argues GLP-1 drugs have upended the diet-trend cycle, reshaping how br...
Investors are spotting a familiar pattern that last showed up in 2020. This piece breaks down what the stock market j...
Awards season is about glamour, opinions, and yes, money. This guide breaks down the costs behind the red carpet, how...
As March 2026 unfolds, a wave of investing apps aimed at college students is reshaping how young people start buildin...
Amphastar delivered a careful Q1 2026 showing steady revenue momentum and margin discipline. This guide breaks down t...
The S&P 500 just completed straight week, marking a notable stretch of gains. This article breaks down what it could ...
Oil prices decline as optimism over a potential Iran conflict settlement grows, lifting expectations for fuel-heavy i...
USMV trailed the S&P 500 over a five-year window, delivering roughly 45% vs. SPY’s 92%, raising questions about the l...
A mobile app rewards users for scrolling, propelling Mode Mobile into Deloitte’s fastest-growing software roster. Sha...
A 24-year-old youth pastor questions whether retirement is feasible on a $2,000 monthly income. Experts urge prioriti...
Software shares rebound after April troughs, lifting the IGV ETF. CrowdStrike's upcoming results are the main catalys...
Ethereum’s latest rally fires up optimism, yet market watchers warn a 15% pullback could unfold in the near term as o...